ACTIVE

ATRYON BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result123,1 k €+291,4 %over 1 year
Gross margin310,7 k €+55,8 %over 1 year
Equity78,5 k €+41,7 %over 1 year

Identity

Source · BCE/KBO

ATRYON BELGIUM is a Private limited company incorporated in 2020. Its main activity is: Management consultancy activities. Its registered office is in Charleroi.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0751.698.530
Incorporation
31/07/2020
Legal form
Private limited company
Registered office
Rue Clément Ader 10
6041 Charleroi · WallonieSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 2000
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin310,7 k €199,5 k €256,4 k €248,7 k €490,8 k €
EBITDA168 k €40 k €-93,8 k €16 k €275,2 k €
Operating result168 k €40 k €-93,8 k €16 k €275,2 k €
Net result123,1 k €31,5 k €-102,9 k €4,2 k €192,6 k €
Balance sheet
Equity78,5 k €55,4 k €23,9 k €126,8 k €122,6 k €
Total assets360,6 k €210,8 k €277,9 k €572,5 k €415 k €
Cash82,2 k €116,8 k €44,6 k €204,9 k €304 k €
Debts269 k €151,8 k €250,3 k €443,5 k €292,4 k €
Other
Workforce––3,8 ETP3,1 ETP1,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 1 ended

Active mandates

David HERBILLON

Director · since 31 juillet 2020

Active
Mohamed HABAZ

Director · since 31 juillet 2020

Active

Ended mandates

David HERBILLON

Managing director · since 31 juillet 2020

Ended

Other companies at this address

Rue Clément Ader 10 6041 Charleroi
CompanyCBE no.
2 Bridge WL● Active
1003.906.745
3D Fibroscreen● Active
1022.772.354
AdipoPharma Belgique● Active
1008.146.338
Brussels South Charleroi BioPark Dev● Active
0479.250.670
ConvEyXo● Active
0725.874.259
CONVEYXO GROUP● Active
1016.957.797
ELKEDONIA BELGIUM● Active
1021.635.177
ENDO TOOLS THERAPEUTICS● Active
0807.570.233
Enodia Therapeutics Belgium● Active
1039.324.811
EU BIOTECH CAMPUS● Active
0776.668.706
Exo-Harvest● Active
0803.425.264
Hemastatx● Active
1019.406.058
Immunofusion● Active
0804.563.629
ImmunXperts● Active
0552.755.587
INCHINN THERAPEUTICS● Active
0799.914.755
INSTAR BELGIQUE● Active
1039.395.085
KOKUMA● Active
0799.078.377
LYS MEDICAL● Active
0688.626.061
MILEUTIS● Active
1011.400.984
Nexelis Europe● Active
0744.498.061

Full financial information

Source · NBB
20252024202320222021
Type of accountMicro modelMicro modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202231/07/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months18 months
Filing date18/07/202608/07/202517/06/202430/05/202303/06/2022
General meeting30/06/202604/06/202527/05/202429/05/202306/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/06/202618/07/2026FrenchPDF
Micro model31/12/202404/06/202508/07/2025FrenchPDF
Abridged model31/12/202327/05/202417/06/2024FrenchPDF
Abridged model31/12/202229/05/202330/05/2023FrenchPDF
Abridged model31/12/202106/05/202203/06/2022FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 1 ended

Active mandates

David HERBILLON

Director · since 31 juillet 2020

Active
Mohamed HABAZ

Director · since 31 juillet 2020

Active

Ended mandates

David HERBILLON

Managing director · since 31 juillet 2020

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office04/11/2025
    SIEGE SOCIAL
    PDF
  • Registered office09/03/2023
    SIEGE SOCIAL
    PDF
  • Other04/08/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025123,1 k €↑
  2. 2024
    Annual accounts 202431,5 k €↑
  3. 2023
    Annual accounts 2023-102,9 k €↓
  4. 2022
    Annual accounts 20224,2 k €↓
  5. 2021
    Annual accounts 2021192,6 k €
  6. 31/07/2020
    IncorporationPrivate limited company